CNIO - Spanish National Cancer Research Centre
José Ignacio Fernández Vera has extensive experience in leadership and management roles within prominent research and scientific institutions in Spain. Currently serving as General Manager Office Attached at CNIO - Spanish National Cancer Research Centre since October 2017, José Ignacio has previously held positions including CEO at Fundación Española para la Ciencia y la Tecnología (FECYT), Advisor for Parliamentary Affairs at the Ministry of Economy, Industry and Competitiveness, and various directorial roles at CNIO, where contributions included directing research support initiatives. José Ignacio also coordinated the science and technology area at the Spanish Embassy in London, fostering the Spanish scientific community in the UK. Additionally, José Ignacio has a proven track record in research transfer coordination and special actions at organizations like ANEP and Genoma España. Education includes a Master's degree in Science, Technology and Society from Universidad de Salamanca, law studies at Università di Siena, and a law degree from Universidad de Salamanca.
This person is not in any teams
CNIO - Spanish National Cancer Research Centre
The Spanish National Cancer Research Centre is a public institution of excellence committed to research, diagnosis and treatment for cancer. The CNIO currently houses 22 Research Groups, organised in 7 Scientific Programmes, plus 5 Clinical Research Unit(s) that work closely with several hospitals. These scientific groups are supported by 19 Core Units that provide state-of-the-art facilities and technical expertise. The CNIO also has an Experimental Therapeutics Programme leader in academic drug discovery. Since 2011, CNIO is recognised a one of the ‘Severo Ochoa’ Centres of Excellence by the Agencia Estatal de Investigación, Ministerio de Ciencia e Innovación -------------------------------- El Centro Nacional de Investigaciones Oncológicas (CNIO) es una institución pública española dedicada a la investigación, diagnóstico y tratamiento del cáncer. El CNIO cubre todo el recorrido de la I+D+i, desde la investigación básica hasta la clínica. Actualmente el CNIO tiene 22 Grupos de Investigación, organizados en 7 Programas Científicos, más 5 Unidades de Investigación Clínica que trabajan estrechamente con varios hospitales. En el CNIO hay 19 Unidades de Apoyo a la Investigación dotadas de las más modernas instalaciones y conocimientos técnicos. El CNIO también tiene un Programa de Terapias Experimentales de referencia en el descubrimiento de nuevos fármacos. Desde el 2011, el CNIO es uno de los Centros de Excelencia Severo Ochoa acreditados por la Agencia Estatal de Investigación, Ministerio de Ciencia e Innovación.